Aralez Bio
Emeryville
About Aralez Bio
Aralez Bio uses engineered enzymes to make valuable products in a sustainable way. The company has invented a novel enzymatic method for synthesizing noncanonical amino acids (ncAAs) also called unusual or unnatural amino acids. Its proprietary approach enables over 100 ncAAs to be synthesized with perfect enantiopurity in just a single step, with water as the only byproduct
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: aralezbio.com
- Phone: (510) 214-2350
Industries & Categories
Biotechnology, Chemical Engineering, Medical
Social Profiles
Canonical: https://fsome.com/organization/aralez-bio-25843 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.